Reporting of Drug Benefit in FDA-Approved Prescription Drug Labeling.

Autor:	Desai, Bansri, Hong, Kyungwan, Powers III, John H., Doshi, Peter, Powers, John H 3rd
Předmět:	DRUG labeling DRUGS TREATMENT effectiveness RANDOM measures META-analysis DRUG approval RESEARCH RESEARCH methodology MEDICAL cooperation EVALUATION research COMPARATIVE studies
Zdroj:	JGIM: Journal of General Internal Medicine; Jan2020, Vol. 35 Issue 1, p377-379, 3p, 2 Charts
Abstrakt:	Obtaining an accurate understanding of the known benefits and risks of drugs is difficult, particularly when drugs first come to market. Drug labels for 78 (76%) indications provided point estimates of drugs' treatment effects, and 73 (72%) and 55 (54%) also reported confidence intervals and I p i values, respectively (Table 1). [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Full text from SpringerLink